首页> 外文OA文献 >Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors

【2h】

Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors

机译：使用基因型部分活性或无活性的核苷/核苷酸逆转录酶抑制剂可提高raltegravir挽救治疗中的病毒抑制率

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Nucleoside reverse transcriptase inhibitors (NRTIs) are often administered in salvage therapy even if genotypic resistance tests (GRTs) indicate high-level resistance, but little is known about the benefit of these additional NRTIs.

机译：即使基因型耐药性测试（GRT）显示出高水平的耐药性，核苷逆转录酶抑制剂（NRTIs）也经常在挽救疗法中给药，但对于这些额外NRTIs的益处知之甚少。

著录项

作者
Scherrer, Alexandra U; von Wyl, Viktor; Böni, Jürg; Yerly Ferrillo, Sabine; Klimkait, Thomas; Bürgisser, Philippe; Garzoni, Christian; Hirschel, Bernard; Cavassini, Matthias; Battegay, Manuel; Vernazza, Pietro L; Bernasconi, Enos; Ledergerber, Bruno; Günthard, Huldrych F;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Viral Suppression Rates in Salvage Treatment With Raltegravir Improved With the Administration of Genotypic Partially Active or Inactive Nucleoside/Tide Reverse Transcriptase Inhibitors. [J] . Gunthard HF JAIDS: Journal of acquired immune deficiency syndromes . 2011,第1期

机译：使用基因型部分活性或无活性的核苷/核苷酸逆转录酶抑制剂可以提高雷洛韦治疗挽救的病毒抑制率。
2. A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPC [J] . MacArthur RD, Novak RM, Peng G, The Lancet . 2006,第9553期

机译：比较三种高活性抗逆转录病毒治疗策略，它们由非核苷类逆转录酶抑制剂和/或蛋白酶抑制剂组成，或在存在核苷类逆转录酶抑制剂作为初始疗法的情况下（CPC）
3. Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience. [J] . Nozza S, Galli L, Visco F, AIDS . 2010,第6期

机译：Raltegravir，maraviroc，etravirine：一种有效的蛋白酶抑制剂和核苷逆转录酶抑制剂节约方案，可用于具有三级经验的HIV感染患者的抢救治疗。
4. Development of 2’-β Seleno Nucleoside Analogs as Irreversible Inhibitors for Viral Reverse Transcriptase [C] . Yasuaki Kimura, Yushi Niimi, Hideo Katakura 日本化学会春季年会講演予稿集 . 2018

机译：2'-β硒核苷类似物作为病毒逆转录酶的不可逆抑制剂
5. Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine [O] . Nicole Bertoletti, Albert H. Chan, Raymond F. Schinazi, 2019

机译：通过HIV-1逆转录酶的结构见解核苷逆转录酶抑制剂：具有逆转录酶的第一晶体结构和Lamivudine和Emtrickamine的活性三磷酸酯形式
6. Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors [O] . Scherrer, A U, von Wyl, V, Böni, J, 2011

机译：使用基因型部分活性或无活性的核苷/核苷酸逆转录酶抑制剂可提高raltegravir挽救治疗中的病毒抑制率

Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors

摘要

著录项

相似文献

相关主题

期刊订阅